Nieuwdorp M - Search Results

1

Oral histidine affects gut microbiota and MAIT cells improving glycemic control in type 2 diabetes patients.

Warmbrunn MV, Attaye I, Aron-Wisnewsky J, Rampanelli E, van der Vossen EWJ, Hao Y, Koopen A, Bergh PO, Stols-Gonçalves D, Mohamed N, Kemper M, Verdoes X, Wortelboer K, Davids M, Belda E, André S, Hazen S, Clement K, Groen B, van Raalte DH, Herrema H, Backhed F, Nieuwdorp M. Warmbrunn MV, et al. Among authors: nieuwdorp m. Gut Microbes. 2024 Jan-Dec;16(1):2370616. doi: 10.1080/19490976.2024.2370616. Epub 2024 Jul 3. Gut Microbes. 2024. PMID: 38961712 Free PMC article.

2

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.

Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, Groen AK, Hoekstra JB, Stroes ES, Nieuwdorp M. Kootte RS, et al. Among authors: nieuwdorp m. Diabetes Obes Metab. 2012 Feb;14(2):112-20. doi: 10.1111/j.1463-1326.2011.01483.x. Epub 2011 Nov 22. Diabetes Obes Metab. 2012. PMID: 21812894 Review.

3

Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.

Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M. Udayappan SD, et al. Among authors: nieuwdorp m. Clin Exp Immunol. 2014 Jul;177(1):24-9. doi: 10.1111/cei.12293. Clin Exp Immunol. 2014. PMID: 24528224 Free PMC article. Review.

4

Microbial modulation of insulin sensitivity.

Khan MT, Nieuwdorp M, Bäckhed F. Khan MT, et al. Among authors: nieuwdorp m. Cell Metab. 2014 Nov 4;20(5):753-760. doi: 10.1016/j.cmet.2014.07.006. Cell Metab. 2014. PMID: 25176147 Free article.

5

Insights into the role of the microbiome in obesity and type 2 diabetes.

Hartstra AV, Bouter KE, Bäckhed F, Nieuwdorp M. Hartstra AV, et al. Among authors: nieuwdorp m. Diabetes Care. 2015 Jan;38(1):159-65. doi: 10.2337/dc14-0769. Diabetes Care. 2015. PMID: 25538312 Review.

6

About the gut microbiome as a pharmacological target in atherosclerosis.

Witjes JJ, van Raalte DH, Nieuwdorp M. Witjes JJ, et al. Among authors: nieuwdorp m. Eur J Pharmacol. 2015 Sep 15;763(Pt A):75-8. doi: 10.1016/j.ejphar.2015.06.023. Epub 2015 Jun 18. Eur J Pharmacol. 2015. PMID: 26096558 Review.

7

Gut Microbiota and Energy Expenditure in Health and Obesity.

Bakker GJ, Zhao J, Herrema H, Nieuwdorp M. Bakker GJ, et al. Among authors: nieuwdorp m. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S13-9. doi: 10.1097/MCG.0000000000000363. J Clin Gastroenterol. 2015. PMID: 26447957 Review.

8

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.

Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Diamant M, Nieuwdorp M, Groen AK, Cahen DL, van Raalte DH. Smits MM, et al. Among authors: nieuwdorp m. Diabetes Obes Metab. 2016 Dec;18(12):1217-1225. doi: 10.1111/dom.12748. Epub 2016 Aug 30. Diabetes Obes Metab. 2016. PMID: 27451030 Free PMC article. Clinical Trial.

9

Causality of small and large intestinal microbiota in weight regulation and insulin resistance.

Scheithauer TP, Dallinga-Thie GM, de Vos WM, Nieuwdorp M, van Raalte DH. Scheithauer TP, et al. Among authors: nieuwdorp m. Mol Metab. 2016 Jun 10;5(9):759-70. doi: 10.1016/j.molmet.2016.06.002. eCollection 2016 Sep. Mol Metab. 2016. PMID: 27617199 Free PMC article.

10

Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.

Koopen AM, Groen AK, Nieuwdorp M. Koopen AM, et al. Among authors: nieuwdorp m. Curr Opin Lipidol. 2016 Dec;27(6):615-622. doi: 10.1097/MOL.0000000000000357. Curr Opin Lipidol. 2016. PMID: 27676197 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters